ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

4,880Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 992

$2.43M Total Retail Price of All Prescriptions

Rank: 3 out of 992

327 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 327 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 2,037 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$498 was the average price of a prescription from this provider, compared to $139 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 4.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
URSODIOL 531 176 10 1 34
OMEPRAZOLE 248 98 2 1
FUROSEMIDE 236 139 3 30
TACROLIMUS 233 70 4 62
METOPROLOL TARTRATE 186 109 5 52
XIFAXAN 181 62 10 6 93
PANTOPRAZOLE SODIUM 176 89 7 2
AMLODIPINE BESYLATE 173 83 8 10
MYCOPHENOLATE MOFETIL 163 31 9 104
PEGASYS 152 36 10 10 119
VIREAD 149 90 11 27
BARACLUDE 149 68 11 23
FLUDROCORTISONE ACETATE 146 57 10 13 127
SPIRONOLACTONE 115 64 14 72
RIBAVIRIN 96 44 10 15 153
PROGRAF 92 41 16 168
VICTRELIS 84 31 10 17 220
PROCRIT 80 31 18 135
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 0 19 203
HYDROXYZINE HCL 64 32 R 20 177
RIBASPHERE 64 15 20 238
PREDNISONE 59 20 22 78
LAMIVUDINE 51 13 23 274
LEVOTHYROXINE SODIUM 50 15 24 17
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.